Skip to content
Dose Brief
Menu

OnlineSemaglutide.org Status Review — Raeliva Name Change

By Updated

OnlineSemaglutide.org now directs readers to Raeliva; confirm the announced migration and your agreement before relying on old prices.

Historical Brief Score68/100Recorded grade CDirectory position by recorded score: 198
Read the Raeliva name-change notice View current availability and member information.
Medication pricing

Current agreement and quote unconfirmed

The announced Raeliva migration does not independently verify an earlier patient’s contract or prescription continuity. Historical amounts are retained below.

Semaglutide: full details

Current OnlineSemaglutide.org agreement and medication quote unknown after its announced Raeliva migration; destination offers have separate terms; earlier listing: From $150/mo (compounded)

Tirzepatide: full details

Current OnlineSemaglutide.org agreement and medication quote unknown after its announced Raeliva migration; do not substitute a destination-brand quote for an earlier agreement; earlier listing: From $399/mo (starting dose, compounded)

Current availability
Raeliva’s migration notice advertises providers in all fifty states; individual treatment eligibility and continuity of an earlier agreement remain unconfirmed.
Prescription offer
Current prescription offer unconfirmed
AvailabilityPrescription availability unconfirmed— OnlineSemaglutide.org now directs readers to Raeliva; confirm the announced migration and your agreement before relying on old prices.

OnlineSemaglutide.org in depth

The name has changed; confirm your own account

OnlineSemaglutide.org now directs visitors to Raeliva. Raeliva’s welcome notice describes a name change under Pacific Shores Research Group, LLC and says it is the same company, providers and support arrangement. These are the company’s statements, rather than an independent verification that every earlier patient agreement or prescription transferred unchanged.

The notice says existing account details carry over and that the card descriptor changes from CV* ONLINE SEMAGLUTIDE to CV* RAELIVA. If you receive an unexpected message, use the independently located official site and confirm the sender before supplying health or payment information. A notice about a rebrand is not proof that a particular charge or prescription belongs to your account.

Raeliva publishes different payment commitments

Raeliva’s current injection pages list semaglutide at $219 monthly, $500 every three months or $900 every six months. Tirzepatide is listed at $299 monthly, $800 every three months or $1,450 every six months. The lowest equivalents require full prepaid charges. These are destination-brand offers, not a promise that an earlier OnlineSemaglutide agreement has those terms; compare the actual agreement using our billing guide.

The destination offers compounded injections and dissolving tablets, which are not FDA-approved brand medicines. Its terms distinguish Pacific Shores’ marketing role, Lion MDs’ independent clinical role and CareValidate’s platform operations. The welcome page advertises providers in all fifty states, but your treatment-state eligibility and assigned pharmacy still require confirmation. Our pharmacy checklist helps separate those roles.

Cancellation does not reverse an existing prescription

Raeliva advertises no charge if clinically ineligible, while its legal terms describe nonrefundable consultation fees once a consultation occurs. Its refund page allows specified billing and fulfillment-error exceptions, and includes a cutoff once medication has been prescribed or prepared for shipment, alongside wording about prescriptions already processed. Do not assume a later refundable window; confirm which event commits your payment.

The welcome and product pages describe cancellation through support or the care team, with written confirmation stopping further charges. That does not reverse an already processed prescription or establish a refund for a prepaid supply. Until your agreement and account continuity are confirmed, treat the historical prices separately from the new destination’s advertisements. Use the refund checklist to check both the next renewal and the current order.

Sources we checked

Public program pages and terms, checked November 2026. We have not enrolled in treatment or independently tested the medication.

This source update covers the review text and stated program terms. The existing numerical score has not been recalculated from this check; it should not be read as a new validation of every score factor.

Historical score

Retained from the earlier program listing; this score does not rate current prescription availability. See the methodology.

Price Stability58/100
Supply Reliability74/100
Transparency72/100
Access Breadth56/100
Clinical Oversight82/100
Track Record73/100

What the sources establish

  • Publishes a specific rebrand notice and changed billing descriptor
  • Destination distinguishes marketing, clinical and platform roles
  • Destination lists full three- and six-month charges

What still needs checking

  • Individual account and contractual continuity are not independently established
  • Lowest destination prices require prepaid commitments
  • Cancellation does not guarantee a processed-prescription refund

The brief

Useful for: Readers who want to understand the announced name change before relying on an earlier treatment agreement. OnlineSemaglutide.org now directs readers to Raeliva; confirm the announced migration and your agreement before relying on old prices.

The score above is a historical assessment of the earlier listing, not a recommendation for current treatment. Compare current provider information before choosing care.

Before you decide

The questions readers ask next after reading about OnlineSemaglutide.org.

Closest here

Directory neighbors by retained score; a status assessment does not establish current prescription availability.

Weighing OnlineSemaglutide.org against one provider in particular? There is a full head-to-head with our top-ranked pick in CoreAge Rx vs OnlineSemaglutide.org, and every provider that outranks it is listed on the OnlineSemaglutide.org alternatives ranking.

More providers we track (24)

514 more are filed too — see every provider we track, ranked.

Pricing, states and verification reflect OnlineSemaglutide.org's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on OnlineSemaglutide.org's site. Not medical advice; see our disclosure.

← Back to all rankings